Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_1
2
22%
Ph phase_4
2
22%
Ph phase_3
1
11%
Ph phase_2
2
22%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (28.6%)
Phase 22 (28.6%)
Phase 31 (14.3%)
Phase 42 (28.6%)

Trials by Status

completed889%
withdrawn111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

NCT04830397
completed

Absorption and Safety of Topical Timolol to Treat Chronic Wounds

NCT04903366
completedphase_4

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

NCT03323164
completedphase_2

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT01707381
completedphase_3

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

NCT00006398
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04830397Phase 2

Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

Completed
NCT04903366

Absorption and Safety of Topical Timolol to Treat Chronic Wounds

Completed
NCT03323164Phase 4

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Completed
NCT01707381Phase 2

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT00006398Phase 3

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

Completed
NCT01607671Phase 1

Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

Withdrawn
NCT00823043

A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Completed
NCT00879099Phase 1

Interaction Study of Timolol Eye Drops and Paroxetine Capsules

Completed
NCT00273442Phase 4

Assessing Cosopt Switch Patients

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9